Press Release: Mirum : Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis

Data on CYP27A1 Variants Available to Genetic Testing Labs Around the World ANN ARBOR, Mich., Feb. 6, 2025 /PRNewswire-PRWeb/ -- Genomenon, Inc., a leading provider of genomic intelligence solutions, has announced a strategic partnership with Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) to...